|
Verzögert
OTC Markets
|
Perf. 5 T | Veränd. 1. Jan. | ||
| - USD | -.--% |
|
-.--% | - |
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Brad Nightingale
PSD | Präsident | 56 | - |
Luke Zouvas
LAW | General Counsel | - | - |
| % | % 5 Tage | Perf. 1 Jahr | Perf. 3 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 0 | ||
| +3.62% | +1.68% | +48.80% | +98.41% | 1’077 Mrd. | ||
| +2.13% | -1.76% | +33.04% | +61.88% | 612 Mrd. | ||
| +3.32% | +4.47% | +23.72% | +91.59% | 501 Mrd. | ||
| +3.80% | +3.21% | +73.99% | +41.69% | 364 Mrd. | ||
| +1.29% | +6.49% | +32.21% | +48.96% | 353 Mrd. | ||
| +1.19% | +5.50% | +19.38% | +42.43% | 278 Mrd. | ||
| +2.30% | +5.82% | -0.47% | +14.69% | 251 Mrd. | ||
| +3.21% | +3.15% | +45.01% | +49.99% | 230 Mrd. | ||
| +3.80% | +4.56% | +29.59% | +97.73% | 190 Mrd. | ||
| Durchschnitt | +1.45% | +1.77% | +33.92% | +60.82% | 385.65 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +1.51% | +1.58% | +37.40% | +69.45% |
Beschäftigte
-
Sektor
Pharmazeutika
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















